Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jeffrey Jorgensen"'
Autor:
Hagop Kantarjian, Fadi G. Haddad, Nitin Jain, Koji Sasaki, Nicholas J. Short, Sanam Loghavi, Rashmi Kanagal-Shamanna, Jeffrey Jorgensen, Issa Khouri, Partow Kebriaei, Yesid Alvarado, Tapan Kadia, Shilpa Paul, Guillermo Garcia-Manero, Bouthaina Dabaja, Musa Yilmaz, Jovitta Jacob, Rebecca Garris, Susan O’Brien, Farhad Ravandi, Elias Jabbour
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background Historically, adults with relapsed-refractory acute lymphoblastic leukemia (ALL) experienced poor outcomes with intensive chemotherapy. This mature analysis explores the benefit of the addition of sequential blinatumomab to low-in
Externí odkaz:
https://doaj.org/article/b4f44ab39b2049e6b4e01db67dec5fb5
Autor:
Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sasha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Jeffrey Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae H. Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Philip A. Thompson, Xavier Troussard, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann, Kanti Rai, Michael Grever
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-7 (2022)
Abstract A significant body of literature has been generated related to the detection of measurable residual disease (MRD) at the time of achieving complete remission (CR) in patients with hairy cell leukemia (HCL). However, due to the indolent natur
Externí odkaz:
https://doaj.org/article/b522c851a9074f98bd78424982d9e633
Autor:
Kamal Chamoun, Sanam Loghavi, Naveen Pemmaraju, Marina Konopleva, Michael Kroll, Madeleine Nguyen-Cao, Marisa Hornbaker, Courtney D. DiNardo, Tapan Kadia, Jeffrey Jorgensen, Michael Andreeff, Shimin Hu, Christopher B. Benton
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-5 (2018)
Abstract Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by neoplastic cells that are positive for CD123, CD4, BDCA2, and TCL1 and aberrant expression of CD56. Historically
Externí odkaz:
https://doaj.org/article/d8e1378666f442c4aef4643e1d9f1fd5
Autor:
Nitin Jain, Xinyan Lu, Naval Daver, Beenu Thakral, Sa A. Wang, Sergej Konoplev, Keyur Patel, Rashmi Kanagal-Shamanna, Marcus Valentine, Guilin Tang, Naveen Pemmaraju, Jeffrey Jorgensen, Partow Kebriaei, Cesar A. Nunez, William Wierda, Elias Jabbour, Kathryn G. Roberts, Charles G. Mullighan, Hagop Kantarjian, Marina Konopleva
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
Externí odkaz:
https://doaj.org/article/26e18557719e4510accaecd44b4d2025
Autor:
Hagop Kantarjian, Nicholas J. Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fadi G. Haddad, Issa Khouri, Courtney D. DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia‐Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias Jabbour
Publikováno v:
American Journal of Hematology. 98:493-501
The combination of ponatinib, a third-generation BCR::ABL1 tyrosine kinase inhibitor, with hyper-CVAD chemotherapy resulted in high rates of complete molecular remissions and survival, without the need for stem cell transplantation (SCT) in most pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::781c6d757b2d4e7b8449a09fbbc2e3c8
https://doi.org/10.1002/ajh.26816
https://doi.org/10.1002/ajh.26816
Autor:
Elias J. Jabbour, Nicholas J. Short, Nitin Jain, Nadya Jammal, Jeffrey Jorgensen, Sa Wang, Xuemei Wang, Maro Ohanian, Yesid Alvarado, Tapan Kadia, Koji Sasaki, Rebecca Garris, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian
Publikováno v:
American Journal of Hematology. 97:1135-1141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3247cc7458fa67844b37e1edf4805346
https://doi.org/10.1002/ajh.26634
https://doi.org/10.1002/ajh.26634
Autor:
Philip Thompson, Michael Keating, Alessandra Ferrajoli, Nitin Jain, Christine Peterson, Naveen Garg, Sa Wang, Jeffrey Jorgensen, Tapan Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas Short, William Wierda
Patients receiving ibrutinib for CLL rarely achieve undetectable measurable residual disease (U-MRD), necessitating indefinite therapy, with cumulative risks of treatment discontinuation due to progression or adverse events. This study added venetocl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5faa5047d4c14dc9d573e88fbddb46dc
https://doi.org/10.21203/rs.3.rs-2414252/v1
https://doi.org/10.21203/rs.3.rs-2414252/v1
Publikováno v:
Science Advances. 8
The general mechanisms by which ESCRTs are specifically recruited to various membranes, and how ESCRT subunits are spatially organized remain central questions in cell biology. At the endosome and lysosomes, ubiquitination of membrane proteins trigge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db450b0b655470864bc11b30ec3ea3b1
https://doi.org/10.1126/sciadv.abm5149
https://doi.org/10.1126/sciadv.abm5149
Autor:
Thomas J, Schall, Jan, Jongstra, Bradley J, Dyer, Jeffrey, Jorgensen, Carol, Clayberger, Mark M, Davis, Alan M, Krensky
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 182(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f1ac7cf14c7ea7d97d3ad37163842930
https://pubmed.ncbi.nlm.nih.gov/19299688
https://pubmed.ncbi.nlm.nih.gov/19299688
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.